v3.25.3
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2025
Revenue Recognition [Abstract]  
Schedule of Revenue by Product Category

The following table presents the Company’s revenue by product category for the nine months ended September 30, 2025, and 2024:

 

   For the Nine Months Ended
September 30,
 
   2025   2024 
Training  $658,844   $400,792 
Product supplies   1,379,117    1,236,472 
Equipment   8,435    121,225 
Patient procedures   1,481,997    838,182 
Total revenue  $3,528,393   $2,596,671 
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Loss

Listed below are the revenues, cost of revenues, gross profits, assets and net loss by Company:

 

   For the Nine Months Ended 
   September 30, 2025 
   Global Stem Cells Group   Regenerative Medical Technology Group   Total 
             
Revenue  $3,528,393   $
-
   $3,528,393 
Cost of revenue   1,497,110    
-
    1,497,110 
Gross profit  $2,031,283   $
-
   $2,031,283 
Gross Profit %   57.57%   0.00%   57.57%
                
Net loss  $(402,871)  $(6,016,695)  $(6,419,566)
Assets  $2,704,271   $1,815,556   $4,519,827